Financials Atreca, Inc.

Equities

BCEL

US04965G1094

Biotechnology & Medical Research

Market Closed - OTC Markets 03:34:26 2024-04-26 pm EDT 5-day change 1st Jan Change
0.08 USD -6.43% Intraday chart for Atreca, Inc. +3.90% -39.39%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Capitalization 1 432.6 592.8 112.6 31.28 3.172 3.172 -
Enterprise Value (EV) 1 432.6 592.8 112.6 31.28 3.172 3.172 3.172
P/E ratio -3.63 x -5.98 x -1.03 x -0.32 x -0.04 x -0.09 x -0.09 x
Yield - - - - - - -
Capitalization / Revenue - - - - - - -
EV / Revenue - - - - - - -
EV / EBITDA - -6,853,175 x -1,064,427 x - - - -
EV / FCF -6,978,354 x - -1,172,444 x -383,273 x - - -
FCF Yield -0% - -0% -0% - - -
Price to Book - - - - - - -
Nbr of stocks (in thousands) 27,961 36,707 37,151 39,067 39,653 39,653 -
Reference price 2 15.47 16.15 3.030 0.8006 0.0800 0.0800 0.0800
Announcement Date 3/11/20 2/25/21 3/3/22 3/29/23 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Net sales 1 - - - - - - - -
EBITDA - - -86.5 -105.8 - - - -
EBIT 1 - -72.57 -88.88 -110.3 -98.3 -81.85 -44.46 -50.69
Operating Margin - - - - - - - -
Earnings before Tax (EBT) 1 - -67.48 -86.33 -109.3 -97.16 -80.04 -42.99 -48.15
Net income 1 -37.94 -67.48 -86.34 -109.3 -97.16 -80.04 -42.99 -48.15
Net margin - - - - - - - -
EPS 2 -108.0 -4.260 -2.700 -2.950 -2.520 -2.040 -0.8600 -0.8650
Free Cash Flow - -61.98 - -96.01 -81.61 - - -
FCF margin - - - - - - - -
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share - - - - - - - -
Announcement Date 4/24/19 3/11/20 2/25/21 3/3/22 3/29/23 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 - - - - - - - - - - - - - - -
EBITDA -27.07 -26.1 -28.14 -25.67 -28.03 -21.93 - -21.53 -18.47 -14.88 - - - - -
EBIT 1 -27.07 -27.52 -29.51 -25.67 -28.03 -23.29 -21.3 -21.53 -19.75 -15.79 -14.33 -9 -9.8 -10 -10.8
Operating Margin - - - - - - - - - - - - - - -
Earnings before Tax (EBT) 1 -26.67 -27.36 -29.52 -24.88 -27.88 -23.06 -21.34 -21.01 -19.19 -36.22 -13.93 -8.8 -9.5 -9.8 -10.5
Net income 1 -26.68 -27.36 -29.52 -24.88 -27.88 -23.06 -21.34 -21.01 -19.19 -36.22 -13.93 -8.8 -9.5 -9.8 -10.5
Net margin - - - - - - - - - - - - - - -
EPS 2 -0.7200 -0.7400 -0.7900 -0.6500 -0.7200 -0.6000 -0.5500 -0.5400 -0.4900 -0.9200 -0.3500 -0.2200 -0.1500 -0.1500 -0.1600
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 8/11/21 11/2/21 3/3/22 5/11/22 8/8/22 11/10/22 3/29/23 5/10/23 8/10/23 11/14/23 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Net Debt - - - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow - -62 - -96 -81.6 - - -
ROE (net income / shareholders' equity) - - - - - - - -
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share - - - - - - - -
Cash Flow per Share - - - - - - - -
Capex - 3.45 5.03 35.1 0.89 - - -
Capex / Sales - - - - - - - -
Announcement Date 4/24/19 3/11/20 2/25/21 3/3/22 3/29/23 - - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.08 USD
Average target price
2 USD
Spread / Average Target
+2,400.00%
Consensus
  1. Stock Market
  2. Equities
  3. BCEL Stock
  4. Financials Atreca, Inc.